ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 5389
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
SKILARENCE 30MG TBL ENT 70
0249882 EU/1/17/1201/013 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 30MG TBL ENT 210
0249883 EU/1/17/1201/014 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 120MG TBL ENT 400
0222277 EU/1/17/1201/011 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 120MG TBL ENT 300
0238541 EU/1/17/1201/012 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 120MG TBL ENT 360
0222276 EU/1/17/1201/010 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 120MG TBL ENT 40
0222268 EU/1/17/1201/002 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 120MG TBL ENT 70
0222269 EU/1/17/1201/003 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 120MG TBL ENT 90
0222270 EU/1/17/1201/004 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 120MG TBL ENT 100
0222271 EU/1/17/1201/005 skilarence.pdf skilarence.pdf L04AX07 R
SKILARENCE 120MG TBL ENT 120
0222272 EU/1/17/1201/006 skilarence.pdf skilarence.pdf L04AX07 R
SKYRIZI 150MG INJ SOL 1X1ML
0255067 EU/1/19/1361/002 skyrizi.pdf skyrizi.pdf L04AC18 R
SKYRIZI 150MG INJ SOL 1X1ML
0255068 EU/1/19/1361/003 skyrizi.pdf skyrizi.pdf L04AC18 R
SKYRIZI 75MG INJ SOL 2X0,83ML
0238450 EU/1/19/1361/001 skyrizi.pdf skyrizi.pdf L04AC18 R
SOLIRIS 300MG INF CNC SOL 1X30ML
0028940 EU/1/07/393/001 soliris.pdf soliris.pdf L04AA25 R
SORAFENIB MYLAN 200MG TBL FLM 112
0252219 44/ 448/19-C sorafenibm.pdf sorafenibm.pdf L01EX02 R
SORAFENIB MYLAN 200MG TBL FLM 112X1
0246729 44/ 448/19-C sorafenibm.pdf sorafenibm.pdf L01EX02 R
SORAFENIB SANDOZ 200MG TBL FLM 56
0239222 44/ 193/19-C sorafenibs.pdf sorafenibs.pdf L01EX02 R
SORAFENIB SANDOZ 400MG TBL FLM 60
0247852 44/ 153/20-C sorafenibs.pdf sorafenibs.pdf L01EX02 R
SORAFENIB SANDOZ 400MG TBL FLM 56
0247851 44/ 153/20-C sorafenibs.pdf sorafenibs.pdf L01EX02 R
SORAFENIB SANDOZ 400MG TBL FLM 30
0247850 44/ 153/20-C sorafenibs.pdf sorafenibs.pdf L01EX02 R

‹‹ ‹ 100 170 180 190 200 210 214 215 216 217 218 219 220 221 222 223 224 230 240 250 260 270 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 1. July 2022 at 01:09
Last update of price and payment data: 1. July 2022 at 01:09